Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,840 | 33,469 | 16,935 | 21,038 | 12,162 |
| TOTAL | $30,337 | $33,842 | $19,441 | $23,917 | $14,470 |
| Non-Current Assets | |||||
| PPE Net | 5 | 9 | 13 | 17 | 21 |
| Other Non-Current Assets | 548 | 594 | 639 | 0 | 0 |
| TOTAL | $553 | $603 | $652 | $17 | $21 |
| Total Assets | $30,890 | $34,445 | $20,093 | $23,934 | $14,491 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,415 | 1,560 | 1,093 | 2,557 | 1,198 |
| Accrued Expenses | 1,735 | 1,223 | 1,194 | 1,220 | 1,098 |
| Other current liabilities | N/A | N/A | 127 | 270 | 498 |
| TOTAL | $3,271 | $2,899 | $2,526 | $4,047 | $2,794 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 490 | 522 | 552 | 0 | 0 |
| TOTAL | $490 | $522 | $552 | $N/A | $N/A |
| Total Liabilities | $3,761 | $3,420 | $3,079 | $4,047 | $2,794 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,262 | 22,262 | 15,362 | 15,362 | 15,285 |
| Common Shares | 7 | 7 | 5 | 5 | 2 |
| Retained earnings | -43,785 | -39,758 | -35,853 | -32,923 | -28,938 |
| TOTAL | $27,130 | $31,025 | $17,015 | $19,888 | $11,698 |
| Total Liabilities And Equity | $30,890 | $34,445 | $20,093 | $23,934 | $14,491 |